Demax Biotech Private Limited
About Demax Biotech Private Limited
Data last updated:
Demax Biotech Private Limited is a private limited company based in Delhi, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 30 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33119DL2014PTC269684. Its GSTIN is 07AAFCD0942G1ZX (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Pawan Kumar Mittal and Gaurav Mittal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Wz – 7 & 8 Ground Floor Phool Bagh Lawrence Road, Delhi, India – 110035.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.19 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹4.15 Lakh (net margin 1%) and EBITDA of ₹15.43 Lakh (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 9% over five years.
Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Demax Biotech Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressWz – 7 & 8 Ground Floor Phool Bagh Lawrence Road, Delhi, India – 110035
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Demax Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Demax Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Demax Biotech Private Limited, buy the company report.
Financials of Demax Biotech Private Limited
FY 2025 filings availableDemax Biotech Private Limited reported revenue of ₹4.19 Cr (up 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 18% growth in the latest year. EBITDA rose 81% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.43 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Demax Biotech Private Limited, buy the company report.
Board of directors of Demax Biotech Private Limited
Demax Biotech has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pawan Kumar Mittal | Director | 30 Jul 2014 | 12 Years 3 Months | Current |
| Gaurav Mittal | Director | 30 Jul 2014 | 12 Years 3 Months | Current |
Peer comparison
Demax Biotech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bumberry Baby Products Private Limited | ₹4.2 Cr (FY 2022) | 29.0% | Kochi, Kerala, India | |||
| Nutriti Life Wins Private Limited | ₹4.2 Cr (FY 2025) | 24.0% | Bhubaneswar, Odisha, India | |||
| Avallone India Exports Private Limited | ₹4.2 Cr (FY 2018) | Mumbai, Maharashtra, India | ||||
| Hie Life Global Technologies Private Limited | ₹4.2 Cr (FY 2025) | 73.0% | Panipat, Haryana, India | |||
| Chetna Spices (India) Private Limited | ₹4.19 Cr (FY 2025) | 19.0% | Uittar Pradesh, Uttar Pradesh, India | |||
| Demax Biotech Private Limitedthis company | ₹4.19 Cr (FY 2025) | ₹4.15 Lakh | 1% | 18.0% | Delhi, India | |
| Gi.En Penta Hi-Tech India Private Limited | ₹4.19 Cr (FY 2024) | 887.0% | Bangalore, Karnataka, India | |||
| Greens India Private Limited | ₹4.19 Cr (FY 2025) | 99.0% | Delhi, India | |||
| Ajanta Handtex Private Limited | ₹4.19 Cr (FY 2025) | -10.0% | Uttar Pradesh, India | |||
| Amrita Engineering and Trading Company Private Limited | ₹4.19 Cr (FY 2024) | 301.0% | Kolkata, West Bengal, India | |||
| Task Distributors Private Limited | ₹4.19 Cr (FY 2025) | -29.0% | Bhosari, Maharashtra, India |
To see the full peer comparison of Demax Biotech Private Limited, buy the company report.
Auditor
Demax Biotech Private Limited is audited by RSD & COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RSD & COMPANY | FY 2017 | 012777N |
Shareholding
The shareholding of Demax Biotech Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Demax Biotech Private Limited, buy the company report.
Legal cases
Demax Biotech Private Limited has 1 court case on record: 1 filed by Demax Biotech. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Civil suit | Filed by the company against an individual | Pending |
To see the full case history of Demax Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Demax Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Demax Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCD0942G1ZX | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Demax Biotech Private Limited, buy the company report.
Recent activity
Demax Biotech Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Gaurav Mittal was appointed as Director on 30 Jul 2014.
Frequently asked questions
Demax Biotech is an active private limited company based in Delhi, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 30 July 2014 (12+ years old) and is registered under CIN U33119DL2014PTC269684.
Demax Biotech has 2 current directors:
- Pawan Kumar Mittal - Director
- Gaurav Mittal - Director
The latest financial statements of Demax Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Demax Biotech is 07AAFCD0942G1ZX, registered in Delhi.
The CIN (Corporate Identification Number) of Demax Biotech is U33119DL2014PTC269684. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Demax Biotech has 1 court case on record: 1 filed by the company. 1 is pending.
Demax Biotech was incorporated on 30 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Demax Biotech by revenue are Bumberry Baby Products Private Limited, Nutriti Life Wins Private Limited, Avallone India Exports Private Limited, Hie Life Global Technologies Private Limited, Chetna Spices (India) Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Gaurav Mittal was appointed as Director on 30 Jul 2014. Pawan Kumar Mittal was appointed as Director on 30 Jul 2014.
The registered office of Demax Biotech is at Wz – 7 & 8 Ground Floor Phool Bagh Lawrence Road, Delhi, India – 110035.
Demax Biotech operates in the healthcare industry, in the other hospital and medical care activities segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
